On November 27, 2020 Australia’s Therapeutics Goods Administration (TGA) state on their website that they “will rigorously assess any COVID-19 vaccine for safety, quality and effectiveness before it can be supplied in Australia.”
On March 29, 2018 the Therapeutics Goods Act was amended to include a Provisional Registration clause to allow products to be provisionally approved upon limited data being assessed.